Lynch Syndrome

Promega's OncoMate MSI system cleared by FDA
By LabPulse.com staff writers
With the FDA clearance, the company said oncologists and pathologists in the U.S. can now access the IVD test that screens for Lynch syndrome in patients with colorectal cancer.
July 29, 2021
2019 05 22 19 44 5254 Dna Red Laser 400
Endometrial cancer patients may benefit from multigene testing
By Emily Hayes
The data are strong enough to support routine testing, researchers reported at the meeting, which is being held in a virtual format from June 4-8.
June 6, 2021
2019 05 15 22 45 9236 Lab Blood Dna 400
Healthy Nevada Project: Community genetic testing needed
By Kate Madden Yee
The study, conducted by researchers from the Healthy Nevada Project, focused on identifying carriers of hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia.
July 28, 2020
2020 07 28 17 56 2985 2020 07 27 Community Screening 400
NCCN revamps guidelines on colon cancer genetic testing
By LabPulse.com staff writers
The NCCN published its "Genetic/Familial High-Risk Assessment: Colorectal" oncology clinical practice guidelines on July 21, in a move the organization said was aimed at making the guidance reflective of new technologies and more intuitive for healthcare providers. Guidelines are available with free registration on the NCCN website.
July 23, 2020
2020 07 23 22 50 7795 Dna Man Woman 400
RNA testing clarifies the unknown in Ambry cancer study
By LabPulse.com staff writers
Earlier this month, the company announced the launch of its +RNAinsight paired testing for RNA and DNA for genes associated with hereditary cancers. The idea is that testing for both provides more information for determining cancer risk.
October 24, 2019
2019 10 24 22 45 3483 Ambry Lab 20191024221827
Invitae provides free testing to pancreatic cancer patients
By LabPulse.com staff writers
Patients must meet criteria in specific clinical areas where genetic testing is underutilized to be eligible for testing. Professional guidelines recommend genetic testing for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials, the company noted in a statement.
September 8, 2019
2019 07 04 00 23 3413 Pancreas New 400
Page 1 of 1